An NIH study published in The Lancet Infectious Disease earlier this month indicates that the anti-malarial medication dihydroartemisinin-piperaquine has failed to treat Plasmodium falciparum malaria
An NIH study published in The Lancet Infectious Disease earlier this month indicates that the anti-malarial medication dihydroartemisinin-piperaquine has failed to treat Plasmodium falciparum malaria